EPISODE · Jun 28, 2018 · 1H 18M
Todd Harrison Discusses Biopharmaceutical Investments
from Masters in Business · host Bloomberg
Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and researching financial market strategies. He was also thefounder and CEO of Minyanville Media Inc., an Emmy-winning financial media company covering global markets in real time. See omnystudio.com/listener for privacy information.
What this episode covers
Todd Harrison Discusses Biopharmaceutical Investments
NOW PLAYING
Todd Harrison Discusses Biopharmaceutical Investments
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m